Prof Lucy Burr is an experienced respiratory physician, training supervisor and clinical trials researcher at Mater Health and Mater Research – University of Queensland (UQ).  She has a PhD (2017) in bronchiectasis microbiology and is an Associate Professor at the School of Medicine, UQ.  She is the Director of Respiratory, Sleep and Cystic Fibrosis medicine at the Mater Hospital, Brisbane and the Deputy Head Medical School (Wellbeing and Success), University of Queensland.

Lucy is recognised nationally for her clinical work on respiratory infections.  She was the chair (2023) of the Acute and Critical Care panel for the National COVID-19 clinical evidence taskforce and was a member of the guideline leadership group.  She is a recent (2019- 2021) convenor of the respiratory infectious disease special interest group of the Thoracic Society of Australia and New Zealand, the Queensland TSANZ branch president and past president (2017-2020), a recent board director of the TSANZ national body and current Chair of the Australasian Bronchiectasis Consortium. Lucy is currently serving on the TSANZ annual scientific meeting and World Bronchiectasis conference steering committees.

Lucy is a respiratory physician and clinician researcher working predominantly in public practice in Sydney. Her clinical practice covers the full range of lung problems but she has a special interest in respiratory infections, bronchiectasis and PCD.

Lucy has a long standing commitment to patients with Bronchiectasis and has been part of the WBC family since the very beginning.

She is
Professor at the University of Sydney, Australia and has academic appointments at Macquarie University and Sydney University with a strong interest in teachingand training junior doctors and lung researchers throughout the Macquarie University Hospital, Nepean Hospital andConcord Hospital Clinical Schools.

She was inaugural chair of the Australasian Bronchiectasis Consortium and clinical lead for the Australian Bronchiectasis Registryproject.

She is currently Chair of Lung Foundation Australia

Prof Thomson is a respiratory physician, specialising in bronchiectasis and NTM infections. She is Australia’s leading clinician-scientist in the field of NTM lung infections. At the University of Queensland she is head of the Greenslopes Clinical Unit, Faculty of Medicine, and leads the Mycobacterial Diseases & Bronchiectasis Research group. Through international connections, she was instrumental in establishing the Australian Bronchiectasis Registry, securing funding and linkages with the European and US registries to facilitate collaborative research. Prof Thomson is lead investigator on clinical trials for NTM and bronchiectasis, and has formed the Australian NTM Research Consortium, to facilitate multisite collaborative NTM research and a biobank facility. In addition to her current roles, she has held several leadership roles within the American Thoracic Society, including board member and Chair of the Pulmonary Infections and TB Assembly (2020-22). Professor Thomson’s clinical work is focussed on specialised clinics for patients with NTM infections and bronchiectasis. Her current research interests include host susceptibility to NTM lung disease, NTM in cystic fibrosis, the gut-lung axis, and the clinical and environmental epidemiology of NTM infection.